Banglao Xu

Dr. Banglao Xu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
YLYuehua Liao
Yuehua Liao
SXShan Xing
Shan Xing
BXBanglao Xu
Banglao Xu
WLWanli Liu
Wanli Liu
GZGe Zhang
Ge Zhang
Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma

1 June 2021 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
BSBowen Shu
Bowen Shu
LLLing Lin
Ling Lin
BWBin Wu
Bin Wu
EHEnqi Huang
Enqi Huang
YWYu Wang
Yu Wang
DLDayu Liu
Dayu Liu

30 July 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
TZTing Zhang
Ting Zhang
ZCZui Chen
Zui Chen
JDJing Deng
Jing Deng
KXKaixiong Xu
Kaixiong Xu
DCDi Che
Di Che
BXBanglao Xu
Banglao Xu
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy ubiquitously associated with Epstein–Barr virus (EBV). EBV generates various viral microRNAs (miRNAs) by processing the BHRF1 and BamHI A rightward (BART) transcripts. These BART miRNAs are abundantly expressed in NPC, but their functions and molecular mechanisms remain largely unknown. Our study found that the EBV-encoded microRNA BART-22 was significantly upregulated in NPC tissues and positively correlated with tumor progression. Furthermore, we found that EBV-miR-BART-22 was a significant predictor of poor prognosis in NPC. A reliable nomogram model to predict the preoperative overall survival (OS) of NPC patients was established. The area under the receiver operating characteristic (ROC) curve value for 5-year survival was 0.91. Elevated levels of EBV-miR-BART-22 significantly promoted the epithelial-mesenchymal transition (EMT) and metastasis of NPC cells in vivo and in vitro. We found that EBV-miR-BART-22 directly targets the 3′-UTR of MOSPD2 mRNA to promote the EMT and metastasis of NPC cells by activating the Wnt/β-catenin signaling pathway. Our findings provide a potential prognostic biomarker and new insight into the molecular mechanisms of NPC metastasis.

26 October 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
BWBin Wu
Bin Wu
XTXinxin Tong
Xinxin Tong
BCBin Chen
Bin Chen
WYWenchang Yuan
Wenchang Yuan
MFMingpeng Fu
Mingpeng Fu
BXBanglao Xu
Banglao Xu
Rapid and accurate identification of CPO may reduce the genetic exchanges among bacteria and prevent further dissemination of carbapenemases to non-CPO. The current method had designed microfluidic chip-based LAMP amplification method for multiplex detection of carbapenemase genes and evaluated the detection performance of the newly method.

11 July 2024 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
ZCZhenhua Chen
Zhenhua Chen
YXYang Xie
Yang Xie
YCYue Cao
Yue Cao
YWYu Wang
Yu Wang
MZMeng Zhao
Meng Zhao
GLGuanfeng Lin
Guanfeng Lin

12 October 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
LHLing Hao
Ling Hao
XYXiao Yang
Xiao Yang
HCHuiling Chen
Huiling Chen
SWShuquan Wei
Shuquan Wei
BXBanglao Xu
Banglao Xu
ZZZiwen Zhao
Ziwen Zhao
Since COVID-19 might have a lasting impact on global public health, it is crucial to analyze its effect on drug-resistant bacterial infections in the respiratory system for the prevention and control of hospital infections. This work aimed to investigate the impact of the COVID-19 outbreak on the clinical distribution and antibiotic resistance of bacterial infection among hospitalized patients in the respiratory unit in order to establish strategies to control antibiotic-resistant infections. Electronic clinical data registry records from 2018 to 2022 were retrospectively analyzed. A total of 36,829 clinical specimens, including sputum, bronchoalveolar lavage fluid, blood, and urine, were collected from 16,073 patients admitted to the Guangzhou First People’s Hospital from January 2018 to December 2022. Among them, 2209 samples were culture-positive. The bacterial isolation rates of different types of samples showed a similar trend from 2019 to 2022, with an increase in 2020 and 2022 and a decrease in 2021. Different bacterial species were separated from different types of samples. The most reported pathogens were identified in sputum samples. Gram-positive isolates were prevalent in urine samples, while Gram-negative bacilli were the predominant pathogenic bacteria isolated from respiratory tract and blood samples. Pseudomonas aeruginosa (P. aeruginosa), Acinetobacter baumannii (A. baumannii) complex, and Klebsiella pneumoniae (K. pneumoniae) were the most abundant Gram-negative bacteria in sputum samples, of which A. baumannii complex had the highest resistance to all tested antibiotics except colistin. Notably, there has been a substantial prevalence of carbapenem-resistant P. aeruginosa, A. baumannii, and K. pneumoniae in the past five years. This alarming situation calls for greater attention and precaution with prescribed antibiotics to limit the generation and spread of new multidrug-resistant bacteria and improve therapeutic management.